Skip to main content

Jason Shafrin, PhD

Jason Shafrin, PhD
Healthcare Economist
12/20/2021
Jason Shafrin, PhD, discusses a paper examining how prices vary for branded, physician-administered drugs which had generic or biosimilar versions introduced before 2005.
Jason Shafrin, PhD, discusses a paper examining how prices vary for branded, physician-administered drugs which had generic or biosimilar versions introduced before 2005.
Jason Shafrin, PhD, discusses a...
12/20/2021
Journal of Clinical Pathways
Jason Shafrin, PhD, FTI Consulting
Guest Blog
08/26/2021
Jason Shafrin, PhD, and David Gruber, MD, MBA, discuss challenges digital health innovators face and what digital health technologies must provide to be successful.
Jason Shafrin, PhD, and David Gruber, MD, MBA, discuss challenges digital health innovators face and what digital health technologies must provide to be successful.
Jason Shafrin, PhD, and David...
08/26/2021
Journal of Clinical Pathways
Shafrin
Healthcare Economist
06/20/2021
Jason Shafrin, PhD, discusses a survey which explored affordability challenges posed by orphan drugs from the payer, provider, and employer perspectives.
Jason Shafrin, PhD, discusses a survey which explored affordability challenges posed by orphan drugs from the payer, provider, and employer perspectives.
Jason Shafrin, PhD, discusses a...
06/20/2021
Journal of Clinical Pathways
Healthcare Economist
06/07/2021
Jason Shafrin, PhD, discusses the many cost aspects of successfully implementing electronic health records.
Jason Shafrin, PhD, discusses the many cost aspects of successfully implementing electronic health records.
Jason Shafrin, PhD, discusses...
06/07/2021
Journal of Clinical Pathways
Healthcare Economist
06/01/2021
Jason Shafrin, PhD, discusses the effect quality impacts during COVID-19 will have on Medicare reimbursement to providers through 2024.
Jason Shafrin, PhD, discusses the effect quality impacts during COVID-19 will have on Medicare reimbursement to providers through 2024.
Jason Shafrin, PhD, discusses...
06/01/2021
Journal of Clinical Pathways
Pharma Insights
12/16/2020
The development and introduction of new pharmaceuticals has played a pivotal role in reducing US cancer deaths. While pharmaceuticals have played a significant role in reducing cancer mortality, winning the war on...
The development and introduction of new pharmaceuticals has played a pivotal role in reducing US cancer deaths. While pharmaceuticals have played a significant role in reducing cancer mortality, winning the war on...
The...
12/16/2020
Journal of Clinical Pathways
Pharma Insights
06/14/2018
While many advancements have been made thus far in the progression toward value-based health care, there are persistent challenges in the measurement of value. In order to deliver value-based care, health care...
While many advancements have been made thus far in the progression toward value-based health care, there are persistent challenges in the measurement of value. In order to deliver value-based care, health care...
While...
06/14/2018
Journal of Clinical Pathways
Pharma Insights
04/11/2017
Cancer has or will affect nearly every person at some point in their lives, either directly or indirectly. The fight against cancer is central to society; in recent years, treatment advances and prevention strategies...
Cancer has or will affect nearly every person at some point in their lives, either directly or indirectly. The fight against cancer is central to society; in recent years, treatment advances and prevention strategies...
Cancer...
04/11/2017
Journal of Clinical Pathways